Global capabilities
Delivering value beyond the test result
At Mayo Clinic Laboratories, laboratory medicine is about more than a test result — it’s about everything that contributes to providing answers for your patients. We develop individualized support solutions for each client that extend through all aspects of the relationship to ensure the delivery of answers, not just results.
Specialized testing areas include:
Global logistics and shipping
We develop unique relationships with each client to individualize logistics support, which is coordinated by a local team who ensures a seamless process before the first patient specimen is sent. Our specialists collaborate with packaging suppliers to create unique solutions that extend the stability of specimens traveling around the world.
These experts ensure specimens are handled carefully and efficiently through close connections to shipping carriers. The air carriers we work with are experienced with processing clinical specimens.
Optimized, expeditious processing
We recognize many medical conditions have a window of opportunity for the best possible outcomes. Our tests and processes are optimized to better serve patients and deliver results with outcomes in mind. We do not triage specimens across a network of labs or use a batch-testing business model. Result turnaround times are expedited by:
- Running tests continuously – your samples are processed alongside those from Mayo Clinic.
- A testing approach that incorporates comprehensive panels and algorithms when appropriate.
- Utilization of Lean and Six Sigma processes.
Reliable connectivity
We offer technology solutions to help our clients connect to us, including a secure online portal with interfacing capabilities that allows you to easily order tests and receive results. Our solutions include:
- Client-friendly test ordering through MayoLINK, which is available in eight languages.
- Expansive website with links to our open- access test catalog, which is updated daily and features comprehensive clinical information, including specimen requirements; clinical and interpretative information; performance; sample test reports; setup files; and pricing.
- 30 country-specific toll-free numbers.
News and updates
The latest
Dr. Bill Morice shares how clinical diagnostics are expanding to guide treatment and enable clinicians to target therapies more precisely.
Topic includes: new vaccine platform invented by Mayo enters COVID-19 clinical trial, Q&A on vaccination and precautions and the new work-life balancing act.
Mayo Clinic’s Advanced Diagnostics Laboratory (ADL) is a visionary space designed to foster innovation. The ADL has a direct impact on patient lives, bringing promising tests and services to patients at Mayo and around the world.
Today's topics feature: Pfizer seeking approval for 3rd vaccine, Minneapolis Fed mandating employees to be vaccinated, U.S. medical stockpile low due to delta variant, shortage of blood donors, COVID-19 vaccine enters clinical trial, and 3 things you can do to improve your heart.
In this episode of Lab Medicine Rounds, Hilary Ryder, M.D., an American Society of Bioethics and Humanities Certified Health Care Ethicist, member of the ethics committee at Texas Health Fort Worth, and former chair of the ethics committee at Dartmouth-Hitchcock Medical Center, discusses medical ethics.
Shawn Mitchell brings a wealth of laboratory expertise to his role as a senior product manager at Mayo Clinic Laboratories, where he puts his knowledge to work promoting Mayo’s innovative infectious disease testing.
This week’s research roundup features a study on how ciliopathy protein HYLS1 coordinates the biogenesis and signaling of primary cilia by activating the ciliary lipid kinase PIPKIγ.
Today's topic includes: Delta variant outbreaks around the world, long COVID afflicting children, is it recommended to get the Pfizer booster after receiving J&J vaccine, vaccine clinical trials, and does vaping make you more susceptible to COVID-19?
The following list includes updates posted to mayocliniclabs.com during the month of June.
Bobbi Pritt, M.D., and William Morice II, M.D., Ph.D., discuss how to prevent, diagnose, and treat vector-borne diseases — illness you get from blood-feeding anthropods like ticks and mosquitos — that are more common during the summertime.
This week’s research roundup features a study on MAP3K7-IKK inflammatory signaling modulates AR protein degradation and prostate cancer progression.
Pua Hopson, D.O., discusses Mayo Clinic Labs’ new disaccharidase activity panel, which measures levels of five digestive enzymes to identify deficiencies that cause carbohydrate maldigestion and can lead to chronic conditions like celiac disease or inflammatory bowel disease. Performed on tissue sample biopsies during upper endoscopy, the activity panel is the gold standard test for detecting disaccharidase deficiencies.
Today's Topics Include: Nearly all COVID deaths are related to the unvaccinated, COVID still being a greater risk to teens than the vaccine, Olympic rules in Tokyo, Mayo Clinic guidance on summer travel, Mayo receives award for recovery after surgery project, and Mayo Q&A on helping COVID long- haulers get back on their feet.